![]() |
|
|
Vol. 293, Issue 3, 912-920, June 2000
Department of Pharmacology and Toxicology (A.R.E., M.D.S., G.D.N.,
J.T.B., T.W.B., M.R.V.) and Department of Anesthesia (M.R.V.), Indiana
University School of Medicine, Indianapolis, Indiana; and Department of
Anesthesiology, University of California at San Diego, La Jolla,
California (H.J., L.S.S.)
Isoprostanes are a novel class of eicosanoids primarily formed
by peroxidation of arachidonic acid. Because of their potential as
inflammatory and/or hyperalgesic agents whose formation is largely
independent of cyclooxygenases, we examined whether 8-iso prostaglandin
E2 (8-iso PGE2) or 8-iso prostaglandin
F2
(8-iso PGF2
) reduces mechanical and
thermal withdrawal threshold in rats, and whether they sensitize rat
sensory neurons. Injection of 1 µg of 8-iso PGE2 (in 2.5 µl) into the hindpaw of rats significantly reduced mechanical and
thermal withdrawal thresholds, whereas 1 µg of 8-iso
PGF2
elicited a transient decrease in only the
mechanical withdrawal threshold. Both isoprostanes enhanced the firing
of C-nociceptors in a concentration-dependent manner when injected into
peripheral receptive fields. Exposing sensory neurons grown in culture
to 1 µM 8-iso PGE2 or 8-iso PGF2
augmented
the number of action potentials elicited by a ramp of depolarizing
current. In contrast, 8-iso PGE2 but not 8-iso
PGF2
enhanced the release of substance P- and calcitonin
gene-related peptide-like immunoreactivity from isolated sensory
neurons. Ten micromolar 8-iso PGE2 stimulated
peptide release directly, whereas treatment with 1 µM 8-iso
PGE2 augmented the release evoked by either bradykinin or
capsaicin. Pretreating neuronal cultures with the nonsteroidal
anti-inflammatory drug ketorolac did not alter the sensitizing action
of 8-iso PGE2 on peptide release, suggesting that this
action of the isoprostane was not secondary to the production of
prostaglandins via the cyclooxygenase pathway. These data support the
notion that isoprostanes are an important class of inflammatory
mediators that augment nociception.
This article has been cited by other articles:
![]() |
D. F. Harney, M. Dooley, B. Harhen, N. McGuiness, G. Cagney, C. McCrory, D. J. Fitzgerald, and N. P. Dowd Nimesulide 90 mg Orally Twice Daily Does Not Influence Postoperative Morphine Requirements After Major Chest Surgery Anesth. Analg., January 1, 2008; 106(1): 294 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Paredes, T. Tazzeo, and L. J. Janssen E-Ring Isoprostane Augments Cholinergic Neurotransmission in Bovine Trachealis via FP Prostanoid Receptors Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 739 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Avalos, C P Chung, A Oeser, G L Milne, J D Morrow, T Gebretsadik, A Shintani, C Yu, and C M Stein Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms Lupus, March 1, 2007; 16(3): 195 - 200. [Abstract] [PDF] |
||||
![]() |
T. L. Yaksh, G. Kokotos, C. I. Svensson, D. Stephens, C. G. Kokotos, B. Fitzsimmons, D. Hadjipavlou-Litina, X.-Y. Hua, and E. A. Dennis Systemic and Intrathecal Effects of a Novel Series of Phospholipase A2 Inhibitors on Hyperalgesia and Spinal Prostaglandin E2 Release J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 466 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. McCrory and S. G. E. Lindahl Cyclooxygenase Inhibition for Postoperative Analgesia Anesth. Analg., July 1, 2002; 95(1): 169 - 176. [Full Text] [PDF] |
||||
![]() |
L. J. Janssen Isoprostanes: an overview and putative roles in pulmonary pathophysiology Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1067 - L1082. [Abstract] [Full Text] [PDF] |
||||